Literature DB >> 23457292

Dynamics intrinsic to cystic fibrosis transmembrane conductance regulator function and stability.

P Andrew Chong1, Pradeep Kota, Nikolay V Dokholyan, Julie D Forman-Kay.   

Abstract

The cystic fibrosis transmembrane conductance regulator (CFTR) requires dynamic fluctuations between states in its gating cycle for proper channel function, including changes in the interactions between the nucleotide-binding domains (NBDs) and between the intracellular domain (ICD) coupling helices and NBDs. Such motions are also linked with fluctuating phosphorylation-dependent binding of CFTR's disordered regulatory (R) region to the NBDs and partners. Folding of CFTR is highly inefficient, with the marginally stable NBD1 sampling excited states or folding intermediates that are aggregation-prone. The severe CF-causing F508del mutation exacerbates the folding inefficiency of CFTR and leads to impaired channel regulation and function, partly as a result of perturbed NBD1-ICD interactions and enhanced sampling of these NBD1 excited states. Increased knowledge of the dynamics within CFTR will expand our understanding of the regulated channel gating of the protein as well as of the F508del defects in folding and function.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23457292      PMCID: PMC3579207          DOI: 10.1101/cshperspect.a009522

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  80 in total

1.  Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis.

Authors:  S H Cheng; R J Gregory; J Marshall; S Paul; D W Souza; G A White; C R O'Riordan; A E Smith
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

2.  Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation.

Authors:  W Dalemans; P Barbry; G Champigny; S Jallat; K Dott; D Dreyer; R G Crystal; A Pavirani; J P Lecocq; M Lazdunski
Journal:  Nature       Date:  1991 Dec 19-26       Impact factor: 49.962

3.  Chloride conductance expressed by delta F508 and other mutant CFTRs in Xenopus oocytes.

Authors:  M L Drumm; D J Wilkinson; L S Smit; R T Worrell; T V Strong; R A Frizzell; D C Dawson; F S Collins
Journal:  Science       Date:  1991-12-20       Impact factor: 47.728

4.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

5.  Demonstration that CFTR is a chloride channel by alteration of its anion selectivity.

Authors:  M P Anderson; R J Gregory; S Thompson; D W Souza; S Paul; R C Mulligan; A E Smith; M J Welsh
Journal:  Science       Date:  1991-07-12       Impact factor: 47.728

6.  Phosphorylation of the R domain by cAMP-dependent protein kinase regulates the CFTR chloride channel.

Authors:  S H Cheng; D P Rich; J Marshall; R J Gregory; M J Welsh; A E Smith
Journal:  Cell       Date:  1991-09-06       Impact factor: 41.582

7.  Cystic fibrosis transmembrane conductance regulator: nucleotide binding to a synthetic peptide.

Authors:  P J Thomas; P Shenbagamurthi; X Ysern; P L Pedersen
Journal:  Science       Date:  1991-02-01       Impact factor: 47.728

8.  State-dependent access of anions to the cystic fibrosis transmembrane conductance regulator chloride channel pore.

Authors:  Mohammad Fatehi; Paul Linsdell
Journal:  J Biol Chem       Date:  2007-12-31       Impact factor: 5.157

9.  Computational studies reveal phosphorylation-dependent changes in the unstructured R domain of CFTR.

Authors:  Tamás Hegedus; Adrian W R Serohijos; Nikolay V Dokholyan; Lihua He; John R Riordan
Journal:  J Mol Biol       Date:  2008-03-26       Impact factor: 5.469

10.  Phenylalanine-508 mediates a cytoplasmic-membrane domain contact in the CFTR 3D structure crucial to assembly and channel function.

Authors:  Adrian W R Serohijos; Tamás Hegedus; Andrei A Aleksandrov; Lihua He; Liying Cui; Nikolay V Dokholyan; John R Riordan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-27       Impact factor: 11.205

View more
  11 in total

Review 1.  Cystic fibrosis transmembrane conductance regulator chloride channel blockers: Pharmacological, biophysical and physiological relevance.

Authors:  Paul Linsdell
Journal:  World J Biol Chem       Date:  2014-02-26

2.  A chemical compound inhibiting the Aha1-Hsp90 chaperone complex.

Authors:  Sandrine C Stiegler; Martin Rübbelke; Vadim S Korotkov; Matthias Weiwad; Christine John; Gunter Fischer; Stephan A Sieber; Michael Sattler; Johannes Buchner
Journal:  J Biol Chem       Date:  2017-08-28       Impact factor: 5.157

Review 3.  CFTR: A New Horizon in the Pathomechanism and Treatment of Pancreatitis.

Authors:  Péter Hegyi; Michael Wilschanski; Shmuel Muallem; Gergely L Lukacs; Miklós Sahin-Tóth; Aliye Uc; Michael A Gray; Zoltán Rakonczay; József Maléth
Journal:  Rev Physiol Biochem Pharmacol       Date:  2016       Impact factor: 5.545

4.  A stable human-cell system overexpressing cystic fibrosis transmembrane conductance regulator recombinant protein at the cell surface.

Authors:  Ellen Hildebrandt; Alok Mulky; Haitao Ding; Qun Dai; Andrei A Aleksandrov; Bekim Bajrami; Pamela Ann Diego; Xing Wu; Marjorie Ray; Anjaparavanda P Naren; John R Riordan; Xudong Yao; Lawrence J DeLucas; Ina L Urbatsch; John C Kappes
Journal:  Mol Biotechnol       Date:  2015-05       Impact factor: 2.695

Review 5.  Architecture and functional properties of the CFTR channel pore.

Authors:  Paul Linsdell
Journal:  Cell Mol Life Sci       Date:  2016-10-03       Impact factor: 9.261

6.  Binding screen for cystic fibrosis transmembrane conductance regulator correctors finds new chemical matter and yields insights into cystic fibrosis therapeutic strategy.

Authors:  Justin D Hall; Hong Wang; Laura J Byrnes; Suman Shanker; Kelong Wang; Ivan V Efremov; P Andrew Chong; Julie D Forman-Kay; Ann E Aulabaugh
Journal:  Protein Sci       Date:  2016-01-12       Impact factor: 6.725

Review 7.  The cystic fibrosis of exocrine pancreas.

Authors:  Michael Wilschanski; Ivana Novak
Journal:  Cold Spring Harb Perspect Med       Date:  2013-05-01       Impact factor: 6.915

Review 8.  Asparaginase treatment side-effects may be due to genes with homopolymeric Asn codons (Review-Hypothesis).

Authors:  Julian Banerji
Journal:  Int J Mol Med       Date:  2015-07-15       Impact factor: 4.101

9.  Mechanisms of CFTR functional variants that impair regulated bicarbonate permeation and increase risk for pancreatitis but not for cystic fibrosis.

Authors:  Jessica LaRusch; Jinsei Jung; Ignacio J General; Michele D Lewis; Hyun Woo Park; Randall E Brand; Andres Gelrud; Michelle A Anderson; Peter A Banks; Darwin Conwell; Christopher Lawrence; Joseph Romagnuolo; John Baillie; Samer Alkaade; Gregory Cote; Timothy B Gardner; Stephen T Amann; Adam Slivka; Bimaljit Sandhu; Amy Aloe; Michelle L Kienholz; Dhiraj Yadav; M Michael Barmada; Ivet Bahar; Min Goo Lee; David C Whitcomb
Journal:  PLoS Genet       Date:  2014-07-17       Impact factor: 5.917

10.  Structure-guided combination therapy to potently improve the function of mutant CFTRs.

Authors:  Guido Veit; Haijin Xu; Elise Dreano; Radu G Avramescu; Miklos Bagdany; Lenore K Beitel; Ariel Roldan; Mark A Hancock; Cecilia Lay; Wei Li; Katelin Morin; Sandra Gao; Puiying A Mak; Edward Ainscow; Anthony P Orth; Peter McNamara; Aleksander Edelman; Saul Frenkiel; Elias Matouk; Isabelle Sermet-Gaudelus; William G Barnes; Gergely L Lukacs
Journal:  Nat Med       Date:  2018-10-08       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.